ICOS and neoplasm: ICOS, as a T cell co‐stimulatory molecule, induces the accumulation of mitochondrial reactive oxygen species (ROS) in tumor cells by promoting the secretion of pro‐inflammatory factors (such as TNF‐α), indirectly activating MPT‐related pathways.